Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinjiang Qikang Habo Uyghur Medicine is a specialized pharmaceutical company dedicated to the research, development, and commercialization of Traditional Uyghur Medicine (TUM). Based in Urumqi, Xinjiang, the company operates as a core subsidiary of the Qikang Investment Group and is a leader in the modernization of ethnic minority pharmaceuticals in China. Its product portfolio includes several proprietary formulations, most notably Zukamu Granules for respiratory ailments and Hanbi Granules for musculoskeletal conditions. The company maintains state-of-the-art GMP-certified manufacturing facilities and integrates traditional herbal knowledge with modern clinical validation. Xinjiang Qikang Habo is recognized as a National High-tech Enterprise and plays a pivotal role in the regional economy through the industrialization of local medicinal resources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 新疆奇康哈博维药.